These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17631550)

  • 1. Nuclear uptake and dosimetry of 64Cu-labeled chelator somatostatin conjugates in an SSTr2-transfected human tumor cell line.
    Eiblmaier M; Andrews R; Laforest R; Rogers BE; Anderson CJ
    J Nucl Med; 2007 Aug; 48(8):1390-6. PubMed ID: 17631550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and biological evaluation of copper-64-labeled tyr3-octreotate using a cross-bridged macrocyclic chelator.
    Sprague JE; Peng Y; Sun X; Weisman GR; Wong EH; Achilefu S; Anderson CJ
    Clin Cancer Res; 2004 Dec; 10(24):8674-82. PubMed ID: 15623652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and biological evaluation of 64Cu-CB-TE2A-sst2-ANT, a somatostatin antagonist for PET imaging of somatostatin receptor-positive tumors.
    Wadas TJ; Eiblmaier M; Zheleznyak A; Sherman CD; Ferdani R; Liang K; Achilefu S; Anderson CJ
    J Nucl Med; 2008 Nov; 49(11):1819-27. PubMed ID: 18927338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of copper-64-labeled somatostatin agonists and antagonist in SSTr2-transfected cell lines that are positive and negative for p53: implications for cancer therapy.
    Nguyen K; Parry JJ; Rogers BE; Anderson CJ
    Nucl Med Biol; 2012 Feb; 39(2):187-97. PubMed ID: 22056254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and biological evaluation of (64)Cu labeled Tyr(3)-octreotate using a phosphonic acid-based cross-bridged macrocyclic chelator.
    Guo Y; Ferdani R; Anderson CJ
    Bioconjug Chem; 2012 Jul; 23(7):1470-7. PubMed ID: 22663248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET of somatostatin receptor-positive tumors using 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the difference.
    Fani M; Del Pozzo L; Abiraj K; Mansi R; Tamma ML; Cescato R; Waser B; Weber WA; Reubi JC; Maecke HR
    J Nucl Med; 2011 Jul; 52(7):1110-8. PubMed ID: 21680701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo evaluation and small-animal PET/CT of a prostate cancer mouse model using 64Cu bombesin analogs: side-by-side comparison of the CB-TE2A and DOTA chelation systems.
    Garrison JC; Rold TL; Sieckman GL; Figueroa SD; Volkert WA; Jurisson SS; Hoffman TJ
    J Nucl Med; 2007 Aug; 48(8):1327-37. PubMed ID: 17631556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of four 64Cu-labeled somatostatin analogues in vitro and in a tumor-bearing rat model: evaluation of new derivatives for positron emission tomography imaging and targeted radiotherapy.
    Lewis JS; Lewis MR; Srinivasan A; Schmidt MA; Wang J; Anderson CJ
    J Med Chem; 1999 Apr; 42(8):1341-7. PubMed ID: 10212119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo evaluation of 64Cu-TETA-Tyr3-octreotate. A new somatostatin analog with improved target tissue uptake.
    Lewis JS; Srinivasan A; Schmidt MA; Anderson CJ
    Nucl Med Biol; 1999 Apr; 26(3):267-73. PubMed ID: 10363797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomographic imaging of copper 64- and gallium 68-labeled chelator conjugates of the somatostatin agonist tyr3-octreotate.
    Nedrow JR; White AG; Modi J; Nguyen K; Chang AJ; Anderson CJ
    Mol Imaging; 2014; 13():. PubMed ID: 25060207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotherapy and dosimetry of 64Cu-TETA-Tyr3-octreotate in a somatostatin receptor-positive, tumor-bearing rat model.
    Lewis JS; Lewis MR; Cutler PD; Srinivasan A; Schmidt MA; Schwarz SW; Morris MM; Miller JP; Anderson CJ
    Clin Cancer Res; 1999 Nov; 5(11):3608-16. PubMed ID: 10589778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonist-antagonist dilemma in molecular imaging: evaluation of a monomolecular multimodal imaging agent for the somatostatin receptor.
    Edwards WB; Xu B; Akers W; Cheney PP; Liang K; Rogers BE; Anderson CJ; Achilefu S
    Bioconjug Chem; 2008 Jan; 19(1):192-200. PubMed ID: 18020401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative dosimetry of copper-64 and yttrium-90-labeled somatostatin analogs in a tumor-bearing rat model.
    Lewis JS; Laforest R; Lewis MR; Anderson CJ
    Cancer Biother Radiopharm; 2000 Dec; 15(6):593-604. PubMed ID: 11190491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes.
    Boswell CA; Sun X; Niu W; Weisman GR; Wong EH; Rheingold AL; Anderson CJ
    J Med Chem; 2004 Mar; 47(6):1465-74. PubMed ID: 14998334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiolabeling of TETA- and CB-TE2A-conjugated peptides with copper-64.
    Wadas TJ; Anderson CJ
    Nat Protoc; 2006; 1(6):3062-8. PubMed ID: 17406569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo evaluation of copper-64-octreotide conjugates.
    Anderson CJ; Pajeau TS; Edwards WB; Sherman EL; Rogers BE; Welch MJ
    J Nucl Med; 1995 Dec; 36(12):2315-25. PubMed ID: 8523125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of somatostatin receptor subtype 2 expression in stably transfected A-427 human cancer cells.
    Parry JJ; Eiblmaier M; Andrews R; Meyer LA; Higashikubo R; Anderson CJ; Rogers BE
    Mol Imaging; 2007; 6(1):56-67. PubMed ID: 17311765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcellular localization of radiolabeled somatostatin analogues: implications for targeted radiotherapy of cancer.
    Wang M; Caruano AL; Lewis MR; Meyer LA; VanderWaal RP; Anderson CJ
    Cancer Res; 2003 Oct; 63(20):6864-9. PubMed ID: 14583484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of four bifunctional chelates for radiolabeling monoclonal antibodies with copper radioisotopes: biodistribution and metabolism.
    Rogers BE; Anderson CJ; Connett JM; Guo LW; Edwards WB; Sherman EL; Zinn KR; Welch MJ
    Bioconjug Chem; 1996; 7(4):511-22. PubMed ID: 8853465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 64Cu-labeled somatostatin analogues conjugated with cross-bridged phosphonate-based chelators via strain-promoted click chemistry for PET imaging: in silico through in vivo studies.
    Cai Z; Ouyang Q; Zeng D; Nguyen KN; Modi J; Wang L; White AG; Rogers BE; Xie XQ; Anderson CJ
    J Med Chem; 2014 Jul; 57(14):6019-29. PubMed ID: 24983404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.